{
  "ptid_time": "021_S_1109_2008-01-10",
  "img_path": "/data/qiuhui/data/adni/images/021_S_1109/2008-01-10/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 28,568 mm³, 1.8% above the reference mean. With a Z-score of 0.04 (51.6th percentile), this represents normal volume ; hippocampal volume measures 4,147 mm³, 41.7% below the reference mean. With a Z-score of -3.83 (0.0th percentile), this represents profound atrophy; whole brain volume measures 795,997 mm³, 18.3% below the reference mean. With a Z-score of -2.31 (1.1th percentile), this represents significant atrophy; entorhinal cortex volume measures 1,916 mm³, 47.8% below the reference mean. With a Z-score of -2.94 (0.2th percentile), this represents significant atrophy; fusiform gyrus volume measures 11,013 mm³, 35.3% below the reference mean. With a Z-score of -3.21 (0.1th percentile), this represents profound atrophy; middle temporal gyrus volume measures 12,406 mm³, 35.3% below the reference mean. With a Z-score of -3.06 (0.1th percentile), this represents profound atrophy. ",
  "text_data": "Age is 78.8 years. Gender is Female. Education: 17 years. MMSE: 20.0. Logical Memory: 0.0. APOEε4 alleles: 1.0. Biomarker levels: Amyloid beta: 404.50 pg/mL (moderate reduced); Total tau: 326.30 pg/mL (mild elevated); Phosphorylated tau: 33.68 pg/mL (moderate elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "Reasoning: The imaging data shows profound atrophy in the hippocampus, entorhinal cortex, fusiform gyrus, and middle temporal gyrus, along with significant whole brain atrophy—all key regions affected in Alzheimer's disease. The clinical profile (MMSE 20, APOE4 carrier, abnormal CSF biomarkers) further supports neurodegeneration consistent with AD.  \n\nDiagnosis: **Dementia (likely Alzheimer’s disease)**  \nConfidence: **High**",
  "timestamp": "2025-07-26T01:36:46.860675"
}